Advanced Search
REN Hailin, LI Xiaona, CHEN Guojun, SUO Jiming, SUN Yan, WANG Jian. Correlation Analysis of miR-20a Expression and Relapse in Formalin-fixed Paraffinembedded Tissue of Urothelial Carcinoma of Bladder[J]. Cancer Research on Prevention and Treatment, 2014, 41(06): 622-625. DOI: 10.3971/j.issn.1000-8578.2014.06.025
Citation: REN Hailin, LI Xiaona, CHEN Guojun, SUO Jiming, SUN Yan, WANG Jian. Correlation Analysis of miR-20a Expression and Relapse in Formalin-fixed Paraffinembedded Tissue of Urothelial Carcinoma of Bladder[J]. Cancer Research on Prevention and Treatment, 2014, 41(06): 622-625. DOI: 10.3971/j.issn.1000-8578.2014.06.025

Correlation Analysis of miR-20a Expression and Relapse in Formalin-fixed Paraffinembedded Tissue of Urothelial Carcinoma of Bladder

More Information
  • Received Date: April 01, 2013
  • Revised Date: July 16, 2013
  • Objective To investigate the feasibility of extracting microRNA from formalin-fixed paraffinembedded(FFPE) tissue of bladder urothelial carcinoma(UC), and analyze the correlation among miR-20a expression, clinicopathologic feature and the relapse. Methods The expression levels of miR-20a in freshly frozen(FF) and FFPE tissues from 50 cases of bladder UC were detected by quantitative real-time PCR. The expression levels of miR-20a in FFPE tissue from 181 cases of bladder UC and its correlation with the relapse in different years were analyzed. Results The expression of miR-20a were closely correlated in FFPE and FF tissue(r=0.792,P<0.001). The expression levels of miR-20a in FFPE tissue in different years were stable (P>0.05). The expression of miR-20a was closely correlated with clinicopathological features. The relapse rate of patients with high expression of miR-20a was signifi cantly higher(P<0.05). Conclusion The expression levels of miR-20a in FF and FFPE tissue of bladder UC were consistency and reliable, hence, it is feasible to extract and study the microRNA in FFPE tissues. The role of miR-20a was correlated with its expression level, and a high expression level is the independent factor of postoperative relapse.
  • [1]
    Ren HL, Sun Y, Li SB, et al.The correlation of E2F3, miR-17- 5p and miR-20a in transitional cell carcinoma of bladder[J]. Zhonghua Mi Niao Wai Ke Za Zhi, 2012, 33(4):264-7.[任海林, 孙 岩, 李世斌,等.膀胱尿路上皮癌细胞株E2F3基因与miR-17-5p和 miR-20a的相互作用[J].中华泌尿外科杂志,2012,33(4):264-7.]
    [2]
    HaiLin Ren, Yan Sun, XiaoNa Li, et al. Expression of E2F3, miR- 17 -5p, miR-20a and their interplay in bladder cancer[J]. Afri J Biotech,2011,10 (53):11028-32.
    [3]
    Lewis BP, Shih IH, Jones-Rhoades MW, et al. Prediction of mammalian microRNA targets[J]. Cell,2003,115(7):787-98.
    [4]
    Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs[J]. Nature, 2005, 433(7027):769-73.
    [5]
    Zhang X, Chen J, Radcliffe T, et al. An Array-based analysis of microRNA expression comparing matched frozen and formalinfixed paraffin-embedded human tissue samples[J]. J Mole Diagn,2008,10(6):513-9.
    [6]
    Xi Y,Nakajima G,Gavin E, et al.Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fi xed paraffi n-embedded samples[J]. RNA,2007,13(10):1668-74.
    [7]
    Bartel DP. MicroRNAs: target recognition and regulatory functions[J]. Cell,2009,136(2):215-33.
    [8]
    Bueno MJ, Gómez de Cedrón M, Laresgoiti U, et al. Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling[J]. Mol Cell Biol,2010,30(12):2983-95.
    [9]
    Altuvia Y, Landgraf P, Lithwick G,et al. Clustering and conservation patterns of human microRNAs[J].Nucleic Acids Res,2005,33(8):2697-706.
    [10]
    He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene[J]. Nature, 2005,435(7043):828-33.
    [11]
    Sylvestre Y, De Guire V, Querido E, et al. An E2F/miR-20a autoregulatory feedback loop[J].J Biol Chem,2007,282(4): 21 35-43.
    [12]
    Matsubara H, Takeuchi T, Nishikawa E, et al. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR- 20 a in lung cancers overexpressing miR-17-92[J]. Oncogene, 20 07,26(41):6099-105.
    [13]
    Aguda BD,Kim Y,Piper-Hunter MG,et al.MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92,E2F,and Myc[J].Proc Natl Acad Sci U S A, 20 08,105(50):19678-83.
  • Related Articles

    [1]MIAO Wenyan, LIN Siying, XU Jianli, WANG Hongbo, JIANG Ming. Effects of Peripheral Blood Stem Cell Transplantation from Haploidentical Versus Matched Sibling Donors on High-risk and Refractory/Relapsed Acute Myeloid Leukemia[J]. Cancer Research on Prevention and Treatment, 2023, 50(10): 988-993. DOI: 10.3971/j.issn.1000-8578.2023.23.0282
    [2]JING Zhengjun, ZHANG Yaqi, BIE Shuang, FAN Qianyu, CHEN Jian. Clinical Value of 131I in Diagnosis and Treatment of Recurrent Papillary Thyroid Carcinoma[J]. Cancer Research on Prevention and Treatment, 2022, 49(6): 628-633. DOI: 10.3971/j.issn.1000-8578.2022.21.1214
    [3]YE Yun, HUANG Linling, ZHONG Yingying, SUN Yufei, ZHANG Qian. Prediction of Disease Specific Survival Rates by Genes Associated with Relapse of Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2016, 43(9): 762-766. DOI: 10.3971/j.issn.1000-8578.2016.09.007
    [4]HUANG Shaojun, WANG Jingjing, JIANG Hua, CAO Hongliang. Value of miR-155 Expression in Forecast of Recurrence or Metastasis and Its Correlation with Serum CEA Levels after Operation[J]. Cancer Research on Prevention and Treatment, 2014, 41(06): 606-609. DOI: 10.3971/j.issn.1000-8578.2014.06.021
    [5]GONG Yaning, LIU Weiqing, ZHANG Nan, HE Yuqin, HONG Min, Dong Jian. Analysis of miR-34a Expression and Funcition in Breast Cancer Tissues and Cells[J]. Cancer Research on Prevention and Treatment, 2013, 40(10): 943-948. DOI: 10.3971/j.issn.1000-8578.2013.10.007
    [6]Qi Weixiang, Tang Li′na, He Aina, Shen Zan, Yao Yang. Evaluation of THP-based Doublet Chemotherapy As Second Line Treatment for Recurrent and Refractory High-grade Osteosarcoma[J]. Cancer Research on Prevention and Treatment, 2012, 39(09): 1128-1131. DOI: 10.3971/j.issn.1000-8578.2012.09.018
    [7]Feng Yanying, Hu Xiaohua, Liu Zhihui, Li Yongqiang, Liao Xiaoli. Evaluation of Modified ProMACE-CytaBOM Regimen in Treating Relapsed or Refractory Patients with Aggressive NHL[J]. Cancer Research on Prevention and Treatment, 2012, 39(02): 201-204. DOI: 10.3971/j.issn.1000-8578.2012.02.021
    [8]LU Wen-bin, JIN Jian-hua, YANG Yu-wei, WANG Fang, LI Xian-wen, ZHANG Hua, GU Xiao-yan. Effect of Gemcitabine Plus Oxaliplatin and Prednisone(GPP) in Treatment of Fwenty Patients with Relapsed or Refractory Non-hodgkin s Lymphoma[J]. Cancer Research on Prevention and Treatment, 2008, 35(02): 121-123. DOI: 10.3971/j.issn.1000-8578.2035
    [9]Tong Jin-xue, . The Analysis of Local Relapse Factors After Excision of Rectal Cancer Retainning Anal[J]. Cancer Research on Prevention and Treatment, 1996, 23(5): 323-324.
    [10]Mao Yongrong. Scanning Electron Microscopic Study of Hodgkin'S Disease in Paraffine-embedded Tissues[J]. Cancer Research on Prevention and Treatment, 1994, 21(6): 352-354.

Catalog

    Article views (1152) PDF downloads (495) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return